These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28189549)

  • 41. Childhood schizotypy and positive symptoms in schizophrenic patients predict schizotypy in relatives.
    Mata I; Sham PC; Gilvarry CM; Jones PB; Lewis SW; Murray RM
    Schizophr Res; 2000 Aug; 44(2):129-36. PubMed ID: 10913744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls.
    Esterberg ML; Jones EM; Compton MT; Walker EF
    Schizophr Res; 2007 Dec; 97(1-3):6-13. PubMed ID: 17897810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive, Negative, and Disorganized Schizotypy Predict Differential Patterns of Interview-Rated Schizophrenia-Spectrum Symptoms and Impairment.
    Kemp KC; Bathery AJ; Barrantes-Vidal N; Kwapil TR
    Assessment; 2021 Jan; 28(1):141-152. PubMed ID: 31955588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eye movement impairment and schizotypal psychopathology.
    Siever LJ; Friedman L; Moskowitz J; Mitropoulou V; Keefe R; Roitman SL; Merhige D; Trestman R; Silverman J; Mohs R
    Am J Psychiatry; 1994 Aug; 151(8):1209-15. PubMed ID: 8037257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baseline dependency of nicotine's sensory gating actions: similarities and differences in low, medium and high P50 suppressors.
    Knott V; de la Salle S; Smith D; Phillipe T; Dort H; Choueiry J; Impey D
    J Psychopharmacol; 2013 Sep; 27(9):790-800. PubMed ID: 23744798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Schizotypy and mentalizing: An fMRI study.
    Acosta H; Straube B; Kircher T
    Neuropsychologia; 2019 Feb; 124():299-310. PubMed ID: 30500664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia?
    Diwadkar VA; Montrose DM; Dworakowski D; Sweeney JA; Keshavan MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):230-8. PubMed ID: 16318899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of personality trait emotionality on acoustic startle response and prepulse inhibition including N100 and P200 event-related potential.
    De Pascalis V; Cozzuto G; Russo E
    Clin Neurophysiol; 2013 Feb; 124(2):292-305. PubMed ID: 22938794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identifying grey matter changes in schizotypy using partial least squares correlation.
    Wiebels K; Waldie KE; Roberts RP; Park HR
    Cortex; 2016 Aug; 81():137-50. PubMed ID: 27208815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased p50 gating but intact prepulse inhibition in borderline personality disorder.
    Grootens KP; van Luijtelaar G; Miller CA; Smits T; Hummelen JW; Buitelaar JK; Verkes RJ
    J Neuropsychiatry Clin Neurosci; 2008; 20(3):348-56. PubMed ID: 18806239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Electrophysiologic endophenotype in schizophrenia].
    Guillin O
    Encephale; 2007 Jun; 33 Pt 3():S369-70. PubMed ID: 19101352
    [No Abstract]   [Full Text] [Related]  

  • 52. Varenicline disrupts prepulse inhibition only in high-inhibitory rats.
    Goktalay T; Buyukuysal S; Uslu G; Coskun AS; Yorgancioglu A; Kayir H; Uzbay T; Goktalay G
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():54-60. PubMed ID: 24632394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of varenicline on sensory gating and exploratory behavior with pretreatment with nicotinic or 5-HT3A receptor antagonists.
    Kucinski A; Wersinger S; Stachowiak EK; Becker C; Lippiello P; Bencherif M; Stachowiak MK
    Behav Pharmacol; 2015 Feb; 26(1-2):217-26. PubMed ID: 25485645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sleep spindles are related to schizotypal personality traits and thalamic glutamine/glutamate in healthy subjects.
    Lustenberger C; O'Gorman RL; Pugin F; Tüshaus L; Wehrle F; Achermann P; Huber R
    Schizophr Bull; 2015 Mar; 41(2):522-31. PubMed ID: 25074975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deficient attentional modulation of the startle response in patients with schizotypal personality disorder.
    Hazlett EA; Levine J; Buchsbaum MS; Silverman JM; New A; Sevin EM; Maldari LA; Siever LJ
    Am J Psychiatry; 2003 Sep; 160(9):1621-6. PubMed ID: 12944337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations between schizotypy and cerebral laterality.
    Park HR; Waldie KE
    Laterality; 2017 Mar; 22(2):195-218. PubMed ID: 26961817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive Functioning and Schizotypy: A Four-Years Study.
    Karamaouna P; Zouraraki C; Giakoumaki SG
    Front Psychiatry; 2020; 11():613015. PubMed ID: 33488431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. α7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia.
    Freedman R
    Annu Rev Med; 2014; 65():245-61. PubMed ID: 24111888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cortical Suppression to Delayed Self-Initiated Auditory Stimuli in Schizotypy: Neurophysiological Evidence for a Continuum of Psychosis.
    Oestreich LK; Mifsud NG; Ford JM; Roach BJ; Mathalon DH; Whitford TJ
    Clin EEG Neurosci; 2016 Jan; 47(1):3-10. PubMed ID: 25898988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neural mechanisms of smooth pursuit eye movements in schizotypy.
    Meyhöfer I; Steffens M; Kasparbauer A; Grant P; Weber B; Ettinger U
    Hum Brain Mapp; 2015 Jan; 36(1):340-53. PubMed ID: 25197013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.